Sort
261,768 grants matching “gene therapy”
Clinical Investigations On The Etiology And Therapy Of Neurogenetic Disorders
$2,724,142Henry F McFarland · Neurological Disorders And Stroke · Z01 · FY2007 · NS
Breast Cancer Family Registry Cohort
$2,723,075Esther M John · Cancer Prevention Instit Of California · UM1 · FY2012 · CA
Lentiviral Gene Therapy for Sickle Cell Disease And Immunodeficiency Disorders
$2,722,946Mitchell J Weiss · St. Jude Children'S Research Hospital · P01 · FY2022 · HL
Overall Application: Burn Trauma Center
$2,721,252Ronald Gary Tompkins · Massachusetts General Hospital · P50 · FY2016 · GM
Overall Application: Burn Trauma Center
$2,721,252Ronald Gary Tompkins · Massachusetts General Hospital · P50 · FY2017 · GM
Discovery of genetic interactions in cancer
$2,720,657Eytan Ruppin · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$2,719,866Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Gene Therapy for Leber Congenital Amaurosis
$2,718,463University Of Florida · U10 · FY2004 · EY
In vivo investigation of sensory hair cell function and development
$2,718,016Katherine Kindt · National Institute On Deafness And Other Communication Disorders · ZIA · FY2021 · DC
ETS GENE FUSIONS AS PREDICTIVE BIOMARKERS OF RESISTANCE TO RADIATION THERAPY FOR PROSTATE CANCER
$2,717,640Regents Of The University Of Michigan · · FY2010 · Department of Defense
Comprehensive Structural and Functional Mapping of Mammalian Colonic Nervous System
$2,717,567Yvette France Tache · University Of California Los Angeles · OT2 · FY2020 · OD
Molecular profiling and immunomodulatory interventions
$2,717,163Abraham Na Shaked · University Of Pennsylvania · U01 · FY2008 · AI
ADalimumab Vs. conventional ImmunoSupprEssion for uveitis(ADVISE) Trial
$2,717,020Janet T. Holbrook · Johns Hopkins University · UG1 · FY2020 · EY
Stem Cell-Engineered Tumor Immunity in Man
$2,716,765David Baltimore · California Institute Of Technology · P01 · FY2013 · CA
Hair Cell Development in the Mammalian Cochlea
$2,716,485Matthew Kelley · National Institute On Deafness And Other Communication Disorders · ZIA · FY2022 · DC
THE PHARMACOGENETICS OF ASTHMA TREATMENT
$2,715,995Brigham And Women'S Hospital · U01 · FY2001 · HL
Determining the function of medium to large diameter sensory neurons in paclitaxel-induced pain via large-scale in vivo DRG imaging
$2,714,830Qin Zheng · Johns Hopkins University · R01 · FY2025 · CA
University of Washington (UW) Mendelian Genomics Data Coordinating Center
$2,714,093Susanne May · University Of Washington · U24 · FY2025 · HG
Genetic and clinical studies of Gaucher disease and other lysosomal disorders
$2,714,052Ellen Sidransky · National Human Genome Research Institute · ZIA · FY2023 · HG
"Genetic and clinical studies of Gaucher disease and other lysosomal disorders"
$2,713,985Ellen Sidransky · Human Genome Research · Z01 · FY2007 · HG
Integrated Nanosystems for Diagnosis and Therapy
$2,713,460Karen L. Wooley · Washington University · U01 · FY2006 · HL
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$2,710,901Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2017 · CA
University of Washington Sexually Transmitted Infections Cooperative Research Cen
$2,710,804Anna Wald · University Of Washington · U19 · FY2017 · AI
Personalized prime editing as a platform for hepatic inborn errors of metabolism
$2,710,325Rebecca Clare Ahrens-Nicklas · Children'S Hosp Of Philadelphia · U01 · FY2025 · TR
Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab
$2,710,272Joren C Madsen · Massachusetts General Hospital · U01 · FY2021 · AI